Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Phase II cancer clinical trials with a one-sample log-rank test and its corrections based on the Edgeworth expansion.
The response rate has been frequently used as the primary endpoint of phase II cancer clinical trials. It may not be an appropriate endpoint when a new treatment is not expected to produce any tumour… Expand
Association Between Anesthesiology Volumes and Early and Late Outcomes After Cystectomy for Bladder Cancer: A Population-Based Study
- M. Jaeger, D. Siemens, X. Wei, P. Peng, C. Booth
- Medicine
- Anesthesia and analgesia
- 1 July 2017
BACKGROUND: Hospital and surgeon volume are related to postoperative complications and long-term survival after radical cystectomy. Here, we describe the relationships between these provider… Expand
Likelihood Ratios for the Emergency Physician
The concept of likelihood ratios was introduced more than 40 years ago, yet this powerful metric has still not seen wider application or discussion in the medical decision-making process. There is… Expand
57 A POPULATION-BASED STUDY OF FACTORS AFFECTING ACCESS TO RADIOTHERAPY FOR ENDOMETRIAL CANCER IN ONTARIO
- T. Hanna, H. Richardson, +4 authors W. Mackillop
- Medicine
- 14 August 2009
Thesis (Master, Community Health & Epidemiology) -- Queen's University, 2009-08-07 22:02:37.308
1869 UTILIZATION AND IMPACT OF PERI-OPERATIVE CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER: A POPULATION-BASED OUTCOMES STUDY
- D. Siemens, Gavin Li, +5 authors C. Booth
- Medicine
- 1 April 2013
Mapping of HIE CT terms to LOINC®: analysis of content-dependent coverage and coverage improvement through new term creation
- P. Peng, Anton Oscar Beitia, +5 authors J. Shapiro
- Computer Science, Medicine
- J. Am. Medical Informatics Assoc.
- 2019
TLDR
Natural Toll-like receptor agonists in prophylactic vaccines for in situ vaccination lymphoma immunotherapy
- P. Peng
- Medicine
- 2016
CLINICAL USE OF HEALTH-RELATED QUALITY OF LIFE OUTCOMES FROM CANCER CLINICAL TRIALS: PRELIMINARY RESULTS FROM A SURVEY OF ONCOLOGISTS
- J. Rouette, J. Blazeby, +6 authors Michael P. Brundage
- Medicine
- Journal of Epidemiology & Community Health
- 7 September 2013
Introduction There have been increasing efforts aimed at enhancing patient-centered care and incorporating patients' voice into clinical practice. As such, a growing body of literature has recognized… Expand
MANAGEMENT AND OUTCOME OF STAGE I SEMINOMA IN ONTARIO.
- H. An, P. Peng, W. Mackillop
- Medicine
- 1 August 2008
Purpose: To describe the uptake and use of surveillance andirradiation in stage I seminoma post-orchiectomy in Ontario and to evaluate theimpact of these management strategies on patient outcomes.… Expand
Natural pattern-recognition-receptor agonists in prophylactic vaccines for in situ vaccination of lymphoma.
- Mark Aleynick, P. Peng, +5 authors J. Brody
- Medicine
- 20 May 2016
e14516Background: In patients with advanced-stage lymphoma, in situ vaccination has yielded partial and complete remissions in phase I/II clinical trials. Though responses have been observed with v...